Skip to main content
. 2020 Aug 11;12(8):2245. doi: 10.3390/cancers12082245

Figure 1.

Figure 1

Flow chart of patient selection. * Inclusion criteria: patients ≥ 18 years, with an Eastern cooperative oncology group (ECOG) performance status ≤ 2 and RAS wild-type tumors. Patients had to be sensitive (patients achieving complete or partial response at the first CT-scan or disease stabilization lasting at least 6 months) or resistant to anti-EGFR blockade (patients showing disease progression at the first CT-scan).